Our Pricing

What Causes Sulphur Burps Mounjaro Timeline: What Happens

Published on: June 03, 2026

Understanding the sulphur burps mounjaro timeline uk helps you prepare for one of the most commonly reported digestive side effects of tirzepatide treatment. Sulphur burps—characterised by a distinctive rotten egg smell caused by hydrogen sulphide gas—typically emerge during the initial titration phase and often resolve as your body adapts to the medication. At Cured Pharmacy, our UK prescribers provide comprehensive support throughout your Mounjaro journey, with treatment starting from £124.99 following a free clinical assessment.

What Causes Sulphur Burps on Mounjaro?

Sulphur burps occur when hydrogen sulphide gas accumulates in your digestive system and is expelled through belching. Mounjaro (tirzepatide) slows gastric emptying as part of its mechanism of action—this is actually how it helps reduce appetite and support weight loss [1]. However, when food remains in your stomach longer than usual, certain proteins break down and produce hydrogen sulphide, resulting in the characteristic rotten egg odour.

As a dual GIP/GLP-1 receptor agonist, tirzepatide affects gut motility more significantly than single-pathway medications. In the SURPASS clinical trial programme, gastrointestinal side effects including eructation (belching) were reported in approximately 8-12% of participants during dose escalation phases [1]. The intensity and frequency of sulphur burps typically correlate with higher doses and rapid titration schedules.

Individual susceptibility varies considerably based on baseline digestive health, dietary composition, and the specific gut microbiome. Patients with pre-existing conditions such as gastroesophageal reflux disease (GERD) or small intestinal bacterial overgrowth (SIBO) may experience more pronounced symptoms during the initial treatment weeks.

Week-by-Week Sulphur Burps Mounjaro Timeline

Weeks 1-4: Initial 2.5mg Dose

Most patients begin noticing mild digestive changes within 48-72 hours of their first injection. Sulphur burps during this starter phase are typically infrequent and mild, affecting approximately 15-20% of new users. Your digestive system is beginning to adjust to slowed gastric emptying, but the low 2.5mg dose minimises severe symptoms for most individuals.

If sulphur burps do occur during weeks 1-4, they're usually isolated incidents rather than persistent daily occurrences. This initial period allows your body to develop tolerance to tirzepatide's gastrointestinal effects before dose escalation begins.

Managing and Preventing Sulphur Burps on Tirzepatide

Staying well-hydrated helps move digestive contents through your system more efficiently. Aim for at least 2-2.5 litres of water daily, spacing intake evenly throughout the day rather than consuming large volumes at once. Peppermint tea and ginger tea have natural carminative properties that may help reduce gas formation and ease digestive discomfort.

Probiotic supplementation may help rebalance gut bacteria and reduce excessive hydrogen sulphide production. Look for multi-strain formulations containing Lactobacillus and Bifidobacterium species. However, always inform your prescriber before starting any new supplements alongside prescription medications.

Dietary Modifications That Help

Reducing sulphur-rich foods significantly decreases hydrogen sulphide production. Limit cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), red meat, eggs, garlic, onions, and dairy products during the first 8-12 weeks of treatment. These foods contain high levels of sulphur-containing amino acids that feed the problematic bacterial fermentation process.

Smaller, more frequent meals reduce the volume of food sitting in your stomach at any given time, minimising fermentation opportunities. Aim for 5-6 smaller portions throughout the day rather than 2-3 large meals. Chewing thoroughly and eating slowly also supports better digestion despite slowed gastric emptying.

Weeks 5-8: Escalation to 5mg Dose

The transition to 5mg represents the most critical period for sulphur burps and other gastrointestinal side effects. Clinical data from the SURPASS trials showed that adverse digestive events peaked during the first dose escalation, with approximately 25-30% of participants reporting increased belching or nausea [2]. This doubling of the active dose intensifies gastric emptying delay, and many patients experience their first significant sulphur burps during weeks 5-8 even if they had no issues previously.

Symptoms during this phase typically manifest 2-4 days after the increased dose injection and may persist for 5-7 days before gradually improving. The burps often occur more frequently after meals, particularly those high in protein or fat. Some patients describe a pattern where symptoms worsen mid-week (3-4 days post-injection when tirzepatide plasma levels peak) then improve slightly before the next weekly dose.

If sulphur burps become severe or are accompanied by persistent nausea, vomiting, or abdominal pain, contact your prescriber immediately. In some cases, maintaining the 2.5mg dose for an additional 4 weeks before escalating allows better tolerance development. Your UK prescriber can adjust your titration schedule based on your individual response—there's no requirement to escalate on the standard 4-week timeline if side effects are problematic.

Weeks 9-16: Higher Maintenance Doses

If sulphur burps persist beyond 16 weeks or worsen rather than improve, further investigation may be warranted. Your prescriber might recommend assessment for underlying conditions such as SIBO, Helicobacter pylori infection, or exocrine pancreatic insufficiency that could be exacerbated by slowed gastric emptying. In rare cases, switching to an alternative GLP-1 medication with different pharmacokinetic properties may be appropriate.

Adaptation and Long-Term Outlook

Most patients experience significant improvement in sulphur burps by weeks 12-16, even as doses increase to 7.5mg, 10mg, or higher maintenance levels. Your digestive system develops tolerance to slowed gastric emptying, and adaptive changes in gut motility patterns reduce fermentation-related gas production. Research indicates that gastrointestinal side effects typically decrease in frequency and severity after the first 2-3 months of treatment [2].

However, approximately 10-15% of long-term Mounjaro users report persistent intermittent sulphur burps, particularly after high-fat or high-protein meals. These individuals often find that maintaining dietary modifications and staying well-hydrated provides adequate symptom control without requiring medication discontinuation.

When to Contact Your UK Prescriber About Sulphur Burps

Red Flag Symptoms Requiring Medical Review

Whilst sulphur burps are generally a benign if unpleasant side effect, certain accompanying symptoms warrant immediate prescriber contact. Seek medical advice if you experience persistent vomiting (more than 24 hours), severe abdominal pain, bloody or black stools, unexplained fever, or signs of dehydration such as reduced urination or extreme thirst. These could indicate more serious gastrointestinal complications requiring clinical assessment.

Additionally, if sulphur burps are so severe that they're preventing adequate nutrition or hydration, or if they're significantly impacting your quality of life despite dietary modifications, your prescriber can discuss dose adjustment strategies or adjunctive treatments. At Cured Pharmacy, our UK clinical team provides ongoing support throughout your treatment journey, ensuring any side effects are appropriately managed whilst optimising your weight loss outcomes.

Scientific References

1. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
4. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
5. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Sulphur burps and other gastrointestinal side effects should be discussed with your prescriber, particularly if severe or persistent.